189 related articles for article (PubMed ID: 37828942)
41. [Analysis of clinical characteristics and risk factors of hepatic fibrosis in children with chronic hepatitis B combined with metabolic-related fatty liver disease].
Li W; Jiang LN; Zhao BK; Liu HY; Zhao JM
Zhonghua Gan Zang Bing Za Zhi; 2023 Jun; 31(6):601-607. PubMed ID: 37400384
[No Abstract] [Full Text] [Related]
42. Waist-to-height ratio, an optimal anthropometric indicator for metabolic dysfunction associated fatty liver disease in the Western Chinese male population.
Cai J; Lin C; Lai S; Liu Y; Liang M; Qin Y; Liang X; Tan A; Gao Y; Lu Z; Wu C; Huang S; Yang X; Zhang H; Kuang J; Mo Z
Lipids Health Dis; 2021 Oct; 20(1):145. PubMed ID: 34706716
[TBL] [Abstract][Full Text] [Related]
43. A Study of Biomarkers Associated with Metabolic Dysfunction-Associated Fatty Liver Disease in Patients with Type 2 Diabetes.
Efrem IC; Moța M; Vladu IM; Mitrea A; Clenciu D; Timofticiuc DCP; Diaconu ID; Turcu A; Crișan AE; Geormăneanu C; Glodeanu AD; Mahler B; Tudor MS; Amzolini AM; Micu SE; Barău Abu Alhija A; Mită A; Filip MM; Forțofoiu M
Diagnostics (Basel); 2022 Oct; 12(10):. PubMed ID: 36292115
[TBL] [Abstract][Full Text] [Related]
44. The prevalence of metabolic-associated fatty liver disease in the Turkish population: A multicenter study.
Yilmaz Y; Yilmaz N; Ates F; Karakaya F; Gokcan H; Kaya E; Adali G; Caliskan Kartal A; Sen I; Ahishali E; Ozenirler S; Koruk M; Uygun A; Idilman R; ;
Hepatol Forum; 2021 May; 2(2):37-42. PubMed ID: 35783905
[TBL] [Abstract][Full Text] [Related]
45. Impact of non-obese metabolic dysfunction-associated fatty liver disease on risk factors for the recurrence of esophageal squamous cell carcinoma treated with endoscopic submucosal dissection: A multicenter study.
Fukunaga S; Mukasa M; Nakane T; Nakano D; Tsutsumi T; Chou T; Tanaka H; Hayashi D; Minami S; Ohuchi A; Nagata T; Takaki K; Takaki H; Miyajima I; Nouno R; Araki T; Morita T; Torimura T; Okabe Y; Kawaguchi T
Hepatol Res; 2024 Feb; 54(2):201-212. PubMed ID: 37796562
[TBL] [Abstract][Full Text] [Related]
46. The metabolic profiles and body composition of lean metabolic associated fatty liver disease.
Cheng YM; Kao JH; Wang CC
Hepatol Int; 2021 Apr; 15(2):405-412. PubMed ID: 33539004
[TBL] [Abstract][Full Text] [Related]
47. Association between metabolic dysfunction-associated fatty liver disease and supraventricular and ventricular tachyarrhythmias in patients with type 2 diabetes.
Mantovani A; Csermely A; Taverna A; Cappelli D; Benfari G; Bonapace S; Byrne CD; Targher G
Diabetes Metab; 2023 Mar; 49(2):101416. PubMed ID: 36586476
[TBL] [Abstract][Full Text] [Related]
48. [Analysis of clinical and pathological features of chronic hepatitis B combined with metabolic-associated fatty liver disease].
Shang MY; Chen YZ; Bao J; Tong YL
Zhonghua Gan Zang Bing Za Zhi; 2023 Feb; 31(2):126-132. PubMed ID: 37137826
[No Abstract] [Full Text] [Related]
49. Healthy Eating Index-2015 in relation to risk of metabolic dysfunction-associated fatty liver disease among US population: National Health and Nutrition Examination Survey 2017-2018.
Zhang W; Wang X; Huang J; Wang S; Yao Q; Li H
Front Nutr; 2022; 9():1043901. PubMed ID: 36712521
[TBL] [Abstract][Full Text] [Related]
50. Serum Adropin as a Potential Biomarker for Predicting the Development of Type 2 Diabetes Mellitus in Individuals With Metabolic Dysfunction-Associated Fatty Liver Disease.
Li N; Xie G; Zhou B; Qu A; Meng H; Liu J; Wang G
Front Physiol; 2021; 12():696163. PubMed ID: 34366886
[No Abstract] [Full Text] [Related]
51. Metabolic Dysfunction-associated Fatty Liver Disease and Mortality Among Chinese Adults: a Prospective Cohort Study.
Wang X; Wu S; Yuan X; Chen S; Fu Q; Sun Y; Lan Y; Hu S; Wang Y; Lu Y; Qu S; Wang L
J Clin Endocrinol Metab; 2022 Jan; 107(2):e745-e755. PubMed ID: 34467980
[TBL] [Abstract][Full Text] [Related]
52. Prevalence and risk factors of metabolic associated fatty liver disease in the contemporary South China population.
Fan J; Luo S; Ye Y; Ju J; Zhang Z; Liu L; Yang J; Xia M
Nutr Metab (Lond); 2021 Sep; 18(1):82. PubMed ID: 34496912
[TBL] [Abstract][Full Text] [Related]
53. High-Sensitive CRP Correlates With the Severity of Liver Steatosis and Fibrosis in Obese Patients With Metabolic Dysfunction Associated Fatty Liver Disease.
Zhu C; Huang D; Ma H; Qian C; You H; Bu L; Qu S
Front Endocrinol (Lausanne); 2022; 13():848937. PubMed ID: 35620390
[TBL] [Abstract][Full Text] [Related]
54. Lean or diabetic subtypes predict increased all-cause and disease-specific mortality in metabolic-associated fatty liver disease.
Chung GE; Yu SJ; Yoo JJ; Cho Y; Lee KN; Shin DW; Kim D; Kim YJ; Yoon JH; Han K; Cho EJ
BMC Med; 2023 Jan; 21(1):4. PubMed ID: 36600263
[TBL] [Abstract][Full Text] [Related]
55. Association between chitinase-3-like protein 1 and metabolic-associated fatty liver disease in patients with type 2 diabetes mellitus.
Zhang F; Han Y; Zheng L; Bao Z; Liu L; Li W
Ir J Med Sci; 2024 Mar; ():. PubMed ID: 38520612
[TBL] [Abstract][Full Text] [Related]
56. Impact of metabolic factors on risk of cardiovascular disease in nondiabetic metabolic dysfunction-associated fatty liver disease.
Kang MK; Lee YR; Jang SY; Tak WY; Kweon YO; Song JE; Loomba R; Park SY; Park JG
Hepatol Int; 2023 Jun; 17(3):626-635. PubMed ID: 37069419
[TBL] [Abstract][Full Text] [Related]
57. Association between complement C3 and the prevalence of metabolic-associated fatty liver disease in a Chinese population: a cross-sectional study.
Feng L; Zhao Y; Wang WL
BMJ Open; 2021 Oct; 11(10):e051218. PubMed ID: 34711595
[TBL] [Abstract][Full Text] [Related]
58. Chinese Visceral Adipose Index Shows Superior Diagnostic Performance in Predicting the Risk of Metabolic Dysfunction Associated Fatty Liver Disease in Early Postmenopausal Chinese Women.
Lu Y; Ge L; Yang H; He Y; Wang Y
Diabetes Metab Syndr Obes; 2023; 16():607-617. PubMed ID: 36909348
[TBL] [Abstract][Full Text] [Related]
59. Prevalence and Risk Factors of Metabolic Associated Fatty Liver Disease in Xinxiang, China.
Li H; Guo M; An Z; Meng J; Jiang J; Song J; Wu W
Int J Environ Res Public Health; 2020 Mar; 17(6):. PubMed ID: 32168920
[TBL] [Abstract][Full Text] [Related]
60. The association between serum uric acid and diabetic complications in patients with type 2 diabetes mellitus by gender: a cross-sectional study.
Hu Y; Li Q; Min R; Deng Y; Xu Y; Gao L
PeerJ; 2021; 9():e10691. PubMed ID: 33520463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
